Seeing Is Believing
Currently out of the existing stock ratings of Karl Keirstead, 171 are a BUY (43.18%), 214 are a HOLD (54.04%), 11 are a SELL (2.78%).
Analyst Karl Keirstead, currently employed at UBS, carries an average stock price target met ratio of 83.98% that have a potential upside of 16.69% achieved within 218 days.
Karl Keirstead’s has documented 750 price targets and ratings displayed on 34 stocks. The coverage is on Technology, Healthcare, Industrials sectors.
Most recent stock forecast was given on CFLT, Confluent at 12-Feb-2025.
Analyst best performing recommendations are on CFLT (CONFLUENT).
The best stock recommendation documented was for CFLT (CONFLUENT) at 2/12/2025. The price target of $34 was fulfilled within 1 day with a profit of $3.9 (12.96%) receiving and performance score of 129.57.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$475
$14.84 (3.22%)
$600
1 months 13 days ago
(08-Jan-2025)
18/24 (75%)
$55.42 (13.21%)
177
Buy
$640
$179.84 (39.08%)
$700
1 months 14 days ago
(07-Jan-2025)
10/15 (66.67%)
$217.37 (51.43%)
195
Hold
$475
$14.84 (3.22%)
$525
1 months 18 days ago
(03-Jan-2025)
11/15 (73.33%)
$44.43 (10.32%)
103
Buy
$625
$164.84 (35.82%)
$685
2 months 9 days ago
(12-Dec-2024)
3/7 (42.86%)
$150.37 (31.68%)
30
Buy
$620
$159.84 (34.74%)
$640
2 months 9 days ago
(12-Dec-2024)
12/18 (66.67%)
$145.37 (30.63%)
179
Which stock is Karl Keirstead is most bullish on?
Which stock is Karl Keirstead is most reserved on?
What Year was the first public recommendation made by Karl Keirstead?